Trending Stories


From the latest healthcare headlines to MedAxiom community news, this is the place to learn more and stay informed. Updated regularly.

CMS Releases Final 2023 Medicare Physician Fee Schedule and Hospital OPPS Rule

News | Published: Tuesday, November 1, 2022

On Nov. 1, the Centers for Medicare and Medicaid Services (CMS) released the 2023 Medicare Physician Fee Schedule (MPFS) Final Rule and 2023 Hospital Outpatient Prospective Payment System (OPPS) Final Rule. Of note, the MPFS conversion factor has been updated from $34.6062 to $33.06, and the overall reimbursement for cardiovascular services is projected to decrease 1% compared with 2022, mostly driven by changes in practice expense payments. Individuals and groups will see different impacts depending on patient populations and services offered.


CMS Finalizes RUC Recommendations For AF, VT and SVT Ablations

News | Published: Tuesday, November 1, 2022

The Centers for Medicare and Medicaid Services (CMS) altered its earlier proposed work relative value units (RVUs) for electrophysiology (EP) ablation services as part of the 2023 Medicare Physician Fee Schedule (MPFS) Final Rule. CMS will implement RVUs recommended by the AMA Relative Value Scale Update Committee (RUC) that are higher than the earlier proposal for SVT, VT, and AF ablation. These values are still lower, overall, than the 2022 work RVUs. RVUs for additional ablations services are unchanged from 2022 or the proposed rule.


Daxor Reveals New Insights in Heart Failure Treatment

Partner News | Published: Monday, October 24, 2022

Daxor Corporation, the global leader in blood volume measurement technology, recently presented new research at the Heart Failure Society of America (HFSA) Annual Scientific Meeting. Blood volume analysis

Atlas Healthcare Partners and MedAxiom Unveil Cardiovascular ASC Solution, MedAtlas CV

News | Published: Tuesday, October 18, 2022

Atlas Healthcare Partners – which specializes in developing and managing ambulatory surgery centers (ASCs) – and MedAxiom – which is dedicated to cardiovascular organizational performance improvement – unveiled their new joint venture, MedAtlas CV.


MedAxiom Partners With Wharton Online to Transform Cardiovascular Business Education

News | Published: Thursday, October 6, 2022

MedAxiom has partnered with Wharton Online to develop a first-of-its-kind business and management program designed specifically for cardiovascular professionals.


HEARTX ACCELERATOR ANNOUNCES FIVE STARTUP COMPANIES SELECTED FOR THE 2022 PROGRAM

News | Published: Thursday, October 6, 2022

HeartX is a cardiovascular-focused healthcare accelerator that facilitates guaranteed hospital pilot projects and clinical trials for accomplished, early-stage companies bringing new cardiovascular innovations to market.


MedAxiom Announces Industry Partnership with Agfa HealthCare

Partner News | Published: Tuesday, September 27, 2022

Agfa HealthCare, a leader in providing strategic guidance to help healthcare providers achieve clinical, operational, and business goals.


MedAxiom Announces Industry Partnership With Apaly Health

Partner News | Published: Monday, September 19, 2022

Apaly Health, Inc., a physician-founded company bridging the gap between employers and providers to directly contract via tech-enabled solutions.


2022 Report: Cardiovascular Provider Compensation and Production Survey

News | Published: Monday, September 19, 2022

MedAxiom’s 10th annual Cardiovascular Provider Compensation and Production Survey Report which unveils trends across cardiology, surgery, advanced practice providers (APPs) and non-clinical compensation reveals dynamic trends in cardiology from the past decade as well as year-over-year insights.


MedAxiom Partner Makes Inc. 5000

Partner News | Published: Tuesday, September 6, 2022

Congratulations to our Industry Partner, Vector Remote Care, for earning a spot in this year’s Inc. 5000! Inc. Magazine recognizes and ranks US-based, privately held companies according to their

Ok
This site uses cookies to improve your experience.

By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.